Back to Search Start Over

Stem cells tightly regulate dead cell clearance to maintain tissue fitness.

Authors :
Stewart KS
Gonzales KA
Yuan S
Tierney MT
Bonny AR
Yang Y
Infarinato NR
Cowley CJ
Levorse JM
Pasolli HA
Ghosh S
Rothlin CV
Fuchs E
Source :
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 22. Date of Electronic Publication: 2023 May 22.
Publication Year :
2023

Abstract

Macrophages and dendritic cells have long been appreciated for their ability to migrate to and engulf dying cells and debris, including some of the billions of cells that are naturally eliminated from our body daily. However, a substantial number of these dying cells are cleared by 'non-professional phagocytes', local epithelial cells that are critical to organismal fitness. How non-professional phagocytes sense and digest nearby apoptotic corpses while still performing their normal tissue functions is unclear. Here, we explore the molecular mechanisms underlying their multifunctionality. Exploiting the cyclical bouts of tissue regeneration and degeneration during the hair cycle, we show that stem cells can transiently become non-professional phagocytes when confronted with dying cells. Adoption of this phagocytic state requires both local lipids produced by apoptotic corpses to activate RXRα, and tissue-specific retinoids for RARγ activation. This dual factor dependency enables tight regulation of the genes requisite to activate phagocytic apoptotic clearance. The tunable phagocytic program we describe here offers an effective mechanism to offset phagocytic duties against the primary stem cell function of replenishing differentiated cells to preserve tissue integrity during homeostasis. Our findings have broad implications for other non-motile stem or progenitor cells which experience cell death in an immune-privileged niche.<br />Competing Interests: Competing Interest E.F. has served on the scientific advisory boards of L’Oreal and Arsenal Biosciences. C.V.R is a senior editor for eLife. S.G. has received grant support from Mirati Therapeutics. The other authors declare no competing interests.

Details

Language :
English
ISSN :
2692-8205
Database :
MEDLINE
Journal :
BioRxiv : the preprint server for biology
Publication Type :
Academic Journal
Accession number :
37293114
Full Text :
https://doi.org/10.1101/2023.05.22.541773